US buyout fund Platinum Equity Advisors is reportedly in discussions to buy Inventia Healthcare, a contract drugmaker based in Mumbai. The deal is said to be valued at ₹2,500 crore ($300 million). Existing investors InvAscent Capital and Jacob Ballas, who together own 40% of Inventia Healthcare, are expected to exit their investments as part of the acquisition. Meanwhile, promoter Janak Shah and his family will retain their stake in the company.